United Dogecoin looks to have its miners operational within approximately 60 days, leveraging low-cost, renewable energy, on its path to being the market’s largest Dogecoin miner by hashrate Gaithersburg, Maryland–(Newsfile Corp. – June 26, 2026) – United Dogecoin Inc....
United Dogecoin shares insights on its digital infrastructure strategy, aimed at expanding revenue opportunities and supporting long-term shareholder value creation. Gaithersburg, Maryland–(Newsfile Corp. – June 25, 2026) – United Dogecoin Inc....
Gaithersburg, Maryland–(Newsfile Corp. – June 9, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), the owner of Molecule.ai, an artificial intelligence (“AI”) driven platform for molecular discovery and early-stage drug development, and United Dogecoin, Inc., Shuttle Pharma’s wholly owned subsidiary and a...
Initial Mining Fleet Targeted for Deployment Within 60 Days of Receipt; To Mine DOGE and LTC and Accumulate Mined Coins as Long-Term Treasury Assets Gaithersburg, Maryland–(Newsfile Corp. – May 14, 2026) – Shuttle Pharmaceutical Holdings, Inc. (NASDAQ:...
The combination and related financing is expected to result in the largest publicly listed Dogecoin mining company based on percentage of the global hashrate Gaithersburg, Maryland–(Newsfile Corp. – May 1, 2026) – Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) (“Shuttle”) has entered into a definitive merger agreement to acquire United Dogecoin Inc....
The combination and related financing is expected to result in the largest publicly listed Dogecoin mining company based on percentage of the global hashrate Gaithersburg, Maryland–(Newsfile Corp. – April 30, 2026) – Shuttle Pharmaceutical Holdings, Inc. (NASDAQ:...
Gaithersburg, Maryland–(Newsfile Corp. – March 27, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), today announced a major advancement to its molecule.ai platform, significantly expanding its capabilities in therapeutic discovery and positioning the Company at the forefront of AI-driven drug development....
Gaithersburg, Maryland–(Newsfile Corp. – March 26, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), today announced a major advancement to its molecule.ai platform, significantly expanding its capabilities in therapeutic discovery and positioning the Company at the forefront of AI-driven drug development....
Gaithersburg, Maryland–(Newsfile Corp. – March 6, 2026) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), the owner of Molecule.ai, an artificial intelligence (“AI”) driven platform for molecular discovery and early-stage drug development, today announced that it has entered into a securities purchase agreement...